Researcher Profiles

All Members

Search by Name (ALL MEMBERS)

Last Name: and/or First Name:

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Show All

Kiran Madura, PhD
Full Member,
Genome Instability and Cancer Genetics Program

Omar M. Mahmoud, MD, MSc, PhD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Sharon L. Manne, PhD
Full Member,
Cancer Prevention and Control Program

Margaret Masterson, MD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Michael P. Matise, PhD
Associate II Member,
Cancer Metabolism and Growth Program

Tara C. Matise, PhD
Full Member,
Clinical Investigations and Precision Therapeutics Program

Fumio Matsumura, PhD
Full Member,
Cancer Metabolism and Growth Program

Tina M. Mayer, MD
Associate I Member,
Clinical Investigations and Precision Therapeutics Program

Danielle E. McCarthy, PhD
Full Member,
Cancer Prevention and Control Program

Kimberly A. McGuigan, PhD, MBA
Associate II Member,
Cancer Prevention and Control Program

Michael McKenna, MD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Kim S. McKim, PhD
Full Member,
Genome Instability and Cancer Genetics Program

Daniel J. Medina, PhD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Janice M. Mehnert, MD
Associate I Member,
Clinical Investigations and Precision Therapeutics Program

Peter W. Melera, PhD
Advisory Member,
Cancer Pharmacology Program

Qingyu Meng, PhD, MS
Associate II Member,
Cancer Prevention and Control Program

Dimitris N. Metaxas, PhD
Full Member,
Clinical Investigations and Precision Therapeutics Program

Bozena (Bo) B. Michniak-Kohn, PhD, MRPharmS
Associate II Member,
Cancer Pharmacology Program

James H. Millonig, PhD
Associate II Member,
Program: non-aligned

Audrey Minden, PhD
Associate II Member,
Cancer Metabolism and Growth Program

Tamara Minko, PhD
Full Member,
Cancer Pharmacology Program

Prabhas V. Moghe, PhD
Full Member,
Cancer Pharmacology Program

Christopher J. Molloy, PhD, RPh
Associate II Member,
Cancer Pharmacology Program

Gaetano T. Montelione, PhD
Full Member,
Genome Instability and Cancer Genetics Program

Elizabeth Moran, PhD
Associate II Member,
Program: non-aligned

Tricia Morino, DO
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Rebecca Moss, MD
Associate I Member,
Clinical Investigations and Precision Therapeutics Program

Sabin Motwani, MD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program

Susan M. Murphy, MD
Associate II Member,
Clinical Investigations and Precision Therapeutics Program